IPP Bureau
Jubilant to invest US $92 mn to expand sterile injectable capacity
By IPP Bureau - June 01, 2021
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
Govt. to give 12 Cr COVID vaccine doses in June 2021
By IPP Bureau - May 31, 2021
7.94 crore doses were made available to the states in May 2021
Margins impacted by high expenses for Pfizer: ICICI Securities
By IPP Bureau - May 31, 2021
Adjusted PAT declined 18.8% YoY
Sun Pharmaceutical’s internals remain strong: ICICI Securities
By IPP Bureau - May 31, 2021
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
Multiple catalysts ahead for Cadila Healthcare: HDFC Securities
By IPP Bureau - May 31, 2021
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
Aurobindo Pharma Q4FY21 consolidated net profit at Rs. 801.58 Cr
By IPP Bureau - May 31, 2021
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
IPCA Q4FY21 consolidated net profit slides QoQ to Rs. 161.34 Cr
By IPP Bureau - May 29, 2021
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
Zydus new initiative to safeguard patients against counterfeit drugs
By IPP Bureau - May 29, 2021
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr
By IPP Bureau - May 29, 2021
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
Glenmark Q4 FY 2020-21 revenue grows 3.3%; Net profit up 6.2%
By IPP Bureau - May 29, 2021
For the year ended March 31, 2021, consolidated revenue was at Rs. 10,943.9 crores as against Rs. 10,641 crores, recording an increase of 2.8% over the previous corresponding period
Zydus Cadila's COVID Vaccine in advance stage of trial; Q4 FY21 income up 3%
By IPP Bureau - May 28, 2021
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
TLC partners Strides to launch Mucormycosis drug in India
By IPP Bureau - May 28, 2021
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Lupin receives US $50 mn on achieving cancer milestone
By IPP Bureau - May 28, 2021
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
Remdesivir demand was exaggerated: Dr. Sharvil Patel
By IPP Bureau - May 28, 2021
Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines
Bharat Biotech signs MoU with GCVC for COVID Vaccine
By IPP Bureau - May 28, 2021
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
